Since elevated RPL19 mRNA occurred as one of a relatively small number of sequences over-expressed in prostate cancer, we hypothesized that its effect was likely to be selective rather than part of a global non-specific elevation in gene expression. The gene discussed is RPL19; the disease is prostate cancer.